PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
- Citation:
- Clin Cancer Res vol 30 (2) 450-461
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 13
- Parents:
- 4072
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Bayer
- Grants:
- U10 CA180821, U10 CA180882, P30 CA008748, P50 CA217694, T32 CA009501, R37 CA241856, R01 FD005105, MSRG-15-064-01-TBG
- Corr. Author:
- Authors:
- Jia Hu Meera R. Hameed Narasimhan P. Agaram Karissa A. Whiting Li-Xuan Qin Anthony M. Villano Rachael B. O'Connor Julian M. Rozenberg Sonia Cohen Katherine Prendergast Sara Kryeziu Richard L. White Mitchell C. Posner Nicholas D. Socci Mrinal M. Gounder Samuel Singer Aimee M. Crago
- Networks:
- LAPS-IL057, LAPS-NC010, LAPS-NY016, NC002
- Study
- Alliance-A151825
- Multiple Studies, or Legacy Studies in Alliance Study:
- Alliance-A091105
- Phases:
- N/A, 3
- Keywords:
- Biomarkers, Prognostic Biomarkers, Drug Mechanisms, Cellular Responses to Anticancer Drugs, Oncogenes & Tumor Suppressors, Oncogenes, Sarcomas, Soft-Tissue Sarcoma, Small Molecule Agents, Kinase Inhibitors, Translational Research, Translational Cancer Mechanisms and Therapy